These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30267212)

  • 1. Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway.
    Fernández D; Guereño M; Lago Huvelle MA; Cercato M; Peters MG
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2399-2418. PubMed ID: 30267212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways.
    Buchanan C; Stigliano I; Garay-Malpartida HM; Rodrigues Gomes L; Puricelli L; Sogayar MC; Bal de Kier Joffé E; Peters MG
    Breast Cancer Res Treat; 2010 Feb; 119(3):559-74. PubMed ID: 19288189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation.
    Stigliano I; Puricelli L; Filmus J; Sogayar MC; Bal de Kier Joffé E; Peters MG
    Breast Cancer Res Treat; 2009 Mar; 114(2):251-62. PubMed ID: 18404367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glypican-3 (GPC3) inhibits metastasis development promoting dormancy in breast cancer cells by p38 MAPK pathway activation.
    Guereño M; Delgado Pastore M; Lugones AC; Cercato M; Todaro L; Urtreger A; Peters MG
    Eur J Cell Biol; 2020 Aug; 99(6):151096. PubMed ID: 32800275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy.
    Bi Y; Jiang Y; Li X; Hou G; Li K
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):499-505. PubMed ID: 33225417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Frizzled-Like Cysteine-Rich Domain in Glypican-3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in Mice.
    Li N; Wei L; Liu X; Bai H; Ye Y; Li D; Li N; Baxa U; Wang Q; Lv L; Chen Y; Feng M; Lee B; Gao W; Ho M
    Hepatology; 2019 Oct; 70(4):1231-1245. PubMed ID: 30963603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling.
    Capurro M; Martin T; Shi W; Filmus J
    J Cell Sci; 2014 Apr; 127(Pt 7):1565-75. PubMed ID: 24496449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling.
    Capurro MI; Xiang YY; Lobe C; Filmus J
    Cancer Res; 2005 Jul; 65(14):6245-54. PubMed ID: 16024626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo.
    Zittermann SI; Capurro MI; Shi W; Filmus J
    Int J Cancer; 2010 Mar; 126(6):1291-301. PubMed ID: 19816934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The loss of glypican-3 induces alterations in Wnt signaling.
    Song HH; Shi W; Xiang YY; Filmus J
    J Biol Chem; 2005 Jan; 280(3):2116-25. PubMed ID: 15537637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma.
    Hu P; Ke C; Guo X; Ren P; Tong Y; Luo S; He Y; Wei Z; Cheng B; Li R; Luo J; Meng Z
    Dig Liver Dis; 2019 Jan; 51(1):120-126. PubMed ID: 30001951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.
    Filmus J; Capurro M
    FEBS J; 2013 May; 280(10):2471-6. PubMed ID: 23305321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newly Constructed Network Models of Different WNT Signaling Cascades Applied to Breast Cancer Expression Data.
    Bayerlová M; Klemm F; Kramer F; Pukrop T; Beißbarth T; Bleckmann A
    PLoS One; 2015; 10(12):e0144014. PubMed ID: 26632845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth.
    Capurro MI; Shi W; Sandal S; Filmus J
    J Biol Chem; 2005 Dec; 280(50):41201-6. PubMed ID: 16227623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines.
    Visweswaran M; Arfuso F; Dilley RJ; Newsholme P; Dharmarajan A
    Int J Biochem Cell Biol; 2018 Feb; 95():63-72. PubMed ID: 29277675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Glypican proteoglycans show intrinsic interactions with Wnt-3a in human prostate cancer cells that are not always associated with cascade activation.
    de Moraes GFA; Listik E; Justo GZ; Vicente CM; Toma L
    BMC Mol Cell Biol; 2021 May; 22(1):26. PubMed ID: 33947326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.
    Matsuda Y; Schlange T; Oakeley EJ; Boulay A; Hynes NE
    Breast Cancer Res; 2009; 11(3):R32. PubMed ID: 19473496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.